日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating Viral Load Sampling Schemes and Swabbing Methods for Optimal Surrogacy

评估病毒载量采样方案和拭子采样方法以实现最佳替代检测

Mateja, Allyson; Chu, Eric; Murray, Thomas A; Bramante, Carolyn T; Moser, Carlee; Givens, Naomi; Abdelghany, Mazin; Blair, Chris; Chen, Shuguang; Lat, Prince Kumar; Harari, Ofir; Kallewaard, Nicole L; Macpherson, Lisa Farmer; Boulware, David R; Suñer, Clara; Mitjà, Oriol; Adam, Stacey J; De Gruttola, Victor; Hughes, Michael D; Rubin, Daniel; Smith, Davey M; Potter, Gail E

Serum Biomarkers in Advanced-Stage AIDS-Associated Kaposi Sarcoma in Resource Limited Settings

资源匮乏环境下晚期艾滋病相关卡波西肉瘤的血清生物标志物

Epeldegui, Marta; Moser, Carlee; Choi, Younjung; Borok, Margaret; Campbell, Thomas B; MacPhail, Patrick; Hosseinipour, Mina C; Samaneka, Wadzanai; Nyirenda, Mulinda; Kosgei, Josphat; Busakhala, Naftali; Martinez-Maza, Otoniel; Krown, Susan E

Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study

ACTIV-2 研究中急性 COVID 期间不同人群的病毒脱落和症状严重程度

Kung, Evelyn; Deo, Rinki; Choudhary, Manish C; Chew, Kara W; Evering, Teresa H; Ignacio, Rachel Bender; Jagannathan, Prasanna; Flynn, James P; Regan, James; Moser, Carlee; Giganti, Mark J; Hughes, Michael D; Ritz, Justin; Javan, Arzhang Cyrus; Greninger, Alexander L; Singh, Upinder; Fischer, William; Daar, Eric S; Wohl, David A; Eron, Joseph J; Currier, Judith S; Coombs, Robert W; Smith, Davey M; Li, Jonathan Z

The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death

在旨在降低28天住院率和/或死亡率的COVID-19治疗早期临床试验中,病毒载量终点的选择

Mateja, Allyson; Chu, Eric; Murray, Thomas A; Bramante, Carolyn T; Moser, Carlee; Givens, Naomi; Abdelghany, Mazin; Blair, Chris; Chen, Shuguang; Lat, Prince Kumar; Harari, Ofir; Kallewaard, Nicole L; Macpherson, Lisa Farmer; Boulware, David R; Suñer, Clara; Mitjà, Oriol; Adam, Stacey J; De Gruttola, Victor; Hughes, Michael D; Rubin, Daniel; Smith, Davey M; Potter, Gail E

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.

在随机安慰剂对照试验中,使用抗严重急性呼吸综合征冠状病毒 2 单克隆抗体疗法后出现病毒和症状反弹

Chew Kara W, McGinley Brooke, Moser Carlee, Li Jonathan Z, Evering Teresa H, Ritz Justin, Javan Arzhang Cyrus, Margolis David, Wohl David A, Hughes Michael D, Daar Eric S, Currier Judith S, Eron Joseph J, Smith Davey M

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

ACTIV-2 研究中,Tixagevimab/cilgavimab 或安慰剂治疗 COVID-19 的安全性、药代动力学以及中和抗体和抗药抗体

Bender Ignacio, Rachel A; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Ritz, Justin; Gibbs, Michael; Kouekam, Hervé Tchouakam; Esser, Mark T; Daar, Eric S; Choudhary, Manish; Deo, Rinki; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Wohl, David Alain

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

通过肌内或静脉注射抗病毒单克隆抗体疗法快速清除可培养的SARS-CoV-2病毒

Deo, Rinki; Choudhary, Manish C; Glover, Owen T; Ignacio, Rachel Bender; Boucau, Julie; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Aga, Evgenia; Gibbs, Michael; Cohen, Taylor; Streicher, Katie; Soboleva, Karina; Fletcher, Courtney V; Daar, Eric S; Greninger, Alexander L; Coombs, Robert W; Fischer, William; Hughes, Michael D; Smith, Davey; Wohl, David Alain; Barczak, Amy K; Li, Jonathan Z

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

在突发传染病大流行背景下实施无缝衔接的二/三期研究设计:从 ACTIV-2 平台 COVID-19 治疗试验中汲取的经验教训

Giganti, Mark J; Chew, Kara W; Moser, Carlee; Eron, Joseph J; Pinilla, Mauricio; Li, Jonathan Z; Ritz, Justin; Javan, Arzhang Cyrus; Wohl, David Alain; Daar, Eric S; Currier, Judith S; Smith, Davey M; Hughes, Michael D

Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study

SLIM LIVER 研究中索马鲁肽对肌肉结构和功能的影响

Ditzenberger, Grace L; Lake, Jordan E; Kitch, Douglas W; Kantor, Amy; Muthupillai, Raja; Moser, Carlee; Belaunzaran-Zamudio, Pablo F; Brown, Todd T; Corey, Kathleen; Landay, Alan L; Avihingsanon, Anchalee; Sattler, Fred R; Erlandson, Kristine M

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

ACTIV-2 试验中,amubarvimab/romlusevimab 与安慰剂相比,对 COVID-19 急性期后结局(包括参与者报告的长期 COVID)的影响

Evering, Teresa H; Moser, Carlee; Jilg, Nikolaus; Ritz, Justin; Wohl, David A; Li, Jonathan Z; Margolis, David; Javan, Arzhang Cyrus; Eron, Joseph J; Currier, Judith S; Daar, Eric S; Smith, Davey M; Hughes, Michael D; Chew, Kara W